SOMA HEALTH vs Mitopure: Which Urolithin A Is Right for You?

Mitopure, made by Timeline, is the urolithin A product that funded much of the original human research. SOMA HEALTH makes a higher-dose gummy at a lower price. This is an honest, like-for-like look at how the two compare on dose, format, evidence, and cost — so you can decide which fits your routine.

If you have spent any time researching urolithin A, you have almost certainly come across Mitopure. It is the flagship product from Timeline (the consumer brand of the Swiss company Amazentis), and it has a legitimate claim to being the most studied urolithin A supplement on the market. SOMA HEALTH makes a competing urolithin A product, so we want to be transparent about that up front: we have a stake in this category. Our aim here is not to talk you out of Mitopure — it is a serious, well-formulated product — but to lay out the real differences so the comparison is useful rather than one-sided.

The short version

Both products deliver clinically studied amounts of urolithin A, the postbiotic compound your gut produces from ellagitannins in foods like pomegranates and walnuts. The clinically studied range in human trials is roughly 500 to 1,000 mg per day. Mitopure's softgels provide 500 mg of urolithin A per two-softgel daily serving. SOMA HEALTH Urolithin A Gummies provide 1,000 mg per four-gummy daily serving — the top of the studied range. The other meaningful differences are format (softgel versus gummy), taste and convenience, and price per month.

Dose: 500 mg versus 1,000 mg

This is the clearest difference. Human trials of urolithin A have generally tested two doses: 500 mg and 1,000 mg per day. In the 2022 study by Singh and colleagues (Cell Reports Medicine), middle-aged adults took either 500 mg or 1,000 mg daily for four months, and both arms were examined for effects on muscle strength and exercise performance. The first-in-human work by Andreux and colleagues in 2019 (Nature Metabolism) established that urolithin A is safe and well tolerated at doses up to 1,000 mg per day, and that it produced a measurable mitochondrial gene-expression signature in blood and muscle.

Mitopure's standard serving sits at the lower end of that range (500 mg). SOMA HEALTH is formulated at 1,000 mg — the higher amount used in the published trials. Higher is not automatically better for every person or every goal, and the research has not established that 1,000 mg reliably outperforms 500 mg for all outcomes. But if your reasoning is "give me the amount at the top of what the human studies used," SOMA HEALTH provides it in a single daily serving. If you prefer to start lower, you can simply take fewer SOMA HEALTH gummies, or choose a 500 mg product. For a fuller discussion of this exact question, see our guide on 500 mg versus 1,000 mg urolithin A.

Format: softgel versus gummy

Mitopure is best known for its softgels (it has also been sold as a powder and in other formats over time). Softgels are compact and flavorless, which some people prefer. The trade-off is that they are pills — if you dislike swallowing capsules, or you tend to forget pills that live in a cabinet, the format can quietly become the reason a bottle goes unfinished.

SOMA HEALTH took the gummy route deliberately. A gummy is easy to take, tastes like raspberry rather than nothing, and tends to get remembered because it feels less like medication. The consistency of a daily habit matters a great deal with urolithin A, because the benefits studied in trials appeared over weeks to months of continuous use, not after a single dose. A format you actually take every day is worth more than a theoretically superior one you skip. If you are weighing formats in general, our explainer on gummies versus capsules goes deeper.

One fair point in Mitopure's favor: because softgels carry no sweeteners or flavoring, they are a cleaner match for anyone who wants the compound and nothing else. SOMA HEALTH's gummies are sugar-free (they use sugar alcohols and natural flavoring to achieve taste without added sugar), which most people prefer, but it is still a different base than a plain softgel.

Evidence: who ran the studies

Here is where intellectual honesty matters most. Much of the foundational human research on urolithin A was funded or conducted by Amazentis, the company behind Mitopure. That is not a knock — pharmaceutical-grade ingredient development is expensive, and Amazentis deserves real credit for taking urolithin A through first-in-human safety work and into randomized trials. It does mean that when you read about urolithin A's benefits, you are often reading about research connected to Mitopure's own ingredient.

The key point for a shopper: the published evidence is about urolithin A the molecule at specific doses, studied as a defined, high-purity compound. SOMA HEALTH uses urolithin A at a clinically studied dose and is third-party tested for identity and purity, so the science on the compound is relevant to any product that delivers a comparable, verified dose. What the trials do not do is compare one brand's finished gummy against another brand's finished softgel head-to-head — no such study exists. Anyone who tells you their specific bottle is "clinically proven" to beat a competitor is overstating what the research shows. For the underlying studies themselves, see our summary of the urolithin A clinical studies.

Price: cost per month

Price is the other practical difference. Verified at the time of writing, Mitopure's softgels are listed around $125 for a 30-serving (one-month) supply at a one-time price, though Timeline's subscription pricing and promotions can lower that. SOMA HEALTH Urolithin A Gummies are $79 for a 30-day supply (120 gummies, four per day). So SOMA HEALTH delivers twice the per-serving dose (1,000 mg versus 500 mg) at a lower monthly price.

Because urolithin A is something you take continuously rather than occasionally, the monthly figure compounds. Over a year, the gap between a roughly $79 product and a roughly $125 product is meaningful, and it is worth weighing against brand familiarity and format preference. Prices change, so confirm current numbers on each brand's site before you decide.

How to choose between them

Choose Mitopure if brand provenance and being closest to the originating research matter most to you, you prefer a flavorless softgel, and the higher price is not a concern. Choose SOMA HEALTH if you want the 1,000 mg dose used at the top of the human trials, you know you will stick with a gummy more reliably than a pill, and you would rather pay less each month for the same molecule. Either way, give it time: the outcomes studied in trials emerged over roughly two to four months of daily use. If you are still deciding across the whole category, our roundups of the best urolithin A gummies and the broader urolithin A guide put both products in context with the rest of the market.

*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. This guide is educational and is not a substitute for advice from a qualified healthcare provider.